- DocumentoResumeenviado porAura Rachmawati
- DocumentoClinical Pathway IPDenviado porAura Rachmawati
- DocumentoPANDUAN IMPLEMENTASI KODE EMERGENSI.docxenviado porAura Rachmawati
- DocumentoDM TPE 2 USIA LANJUT.pdfenviado porAura Rachmawati
- Documento297570846-FORMULIR-DPJP.docxenviado porAura Rachmawati
- Documento377977395 Panduan Code Redenviado porAura Rachmawati
- DocumentoPanduan Implementasi Kode-kode Emergensienviado porAura Rachmawati
- DocumentoPANDUAN_IMPLEMENTASI_KODE-KODE_EMERGENSI.docxenviado porAura Rachmawati
- Documento297570846-FORMULIR-DPJPenviado porAura Rachmawati
- Documento297570846-FORMULIR-DPJP.docxenviado porAura Rachmawati
- DocumentoDM TPE 2 USIA LANJUT.pdfenviado porAura Rachmawati
- DocumentoDM pada usia lanjut.pdfenviado porAura Rachmawati
- Documentoinfodatin-diabetes.pdfenviado porAura Rachmawati
- DocumentoLeaflet Supri 1enviado porAura Rachmawati
- DocumentoCairan Dan Elektrolit Des 09enviado porAura Rachmawati
- DocumentoSubclinical Hypothyroid in Children and Adolescentsenviado porAura Rachmawati
- Documentodetection of thyroid dysfunction in early pregnancy.pdfenviado porAura Rachmawati
- Documentojcem-44-3-481--enviado porAura Rachmawati
- DocumentoSchneider_et_al-2013-CA-_A_Cancer_Journal_for_Clinicians.pdfenviado porAura Rachmawati
- Documentodokumen.tips_laporan-kasus-hernia-55844c715fead.docxenviado porAura Rachmawati
- Documentonejmoa1310214[1]enviado porAura Rachmawati
- DocumentoARIA_PG_08_View_WM[1].pdfenviado porAura Rachmawati
- Documento02-Pelayanan_Imunisasi[1].pdfenviado porAura Rachmawati
- DocumentoSchneider_et_al-2013-CA-_A_Cancer_Journal_for_Clinicians.pdfenviado porAura Rachmawati
- DocumentoTargeting the RET Pathway in Thyroid Cancerenviado porAura Rachmawati
- DocumentoPhase II Trial of Sorafenib in Advanced Thyroid Cancerenviado porAura Rachmawati
- DocumentoChemotherapy for Colorectalncancerenviado porAura Rachmawati
- DocumentoPrevalence and Risk Factors of Subclinical Thyroid Diseaseenviado porAura Rachmawati
- DocumentoPrevalence and Risk Factors of Subclinical Thyroid Diseaseenviado porAura Rachmawati
- DocumentoThyroid Cancer Emerging Role for Targeted Therapiesenviado porAura Rachmawati
- DocumentoProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancerenviado porAura Rachmawati
- DocumentoNew Treatment Modalities in Advanced Thyroid Cancerenviado porAura Rachmawati
- DocumentoNew Targeted Therapies for Thyroid Cancerenviado porAura Rachmawati
- DocumentoProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancerenviado porAura Rachmawati
- DocumentoNew Targeted Therapies for Thyroid Cancerenviado porAura Rachmawati
- DocumentoAJHO Apr15 10 Thyroidenviado porAura Rachmawati
- DocumentoPinestreet.pptxenviado porAura Rachmawati
- DocumentoDiabetes Control in Thyroid Diseaseenviado porAura Rachmawati
- DocumentoThyroid Size and Goiter Prevalence After Introduction of Iodized Saltenviado porAura Rachmawati
- DocumentoDetection of Thyroid Dysfunction in Early Pregnancyenviado porAura Rachmawati
- DocumentoProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancerenviado porAura Rachmawati
- DocumentoDetection of Thyroid Dysfunction in Early Pregnancyenviado porAura Rachmawati
- DocumentoAirAsia Prospectus Local English 20101029enviado porAura Rachmawati
- DocumentoCitibank Finalenviado porAura Rachmawati
- DocumentoAsahi Glassenviado porAura Rachmawati
- DocumentoAsahi Glassenviado porAura Rachmawati
- DocumentoNokiaenviado porAura Rachmawati
- Documento1. Cover okenviado porAura Rachmawati
- DocumentoData Imunisasi Di Puskesmas Tegal Angusenviado porAura Rachmawati